Drug · DIN 02274396
AZITHROMYCIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 4, 2025; first marketed April 19, 2006.
- Drug Identification Number (DIN)
- 02274396
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Azithromycin J01FA10
- Class
- Human
- Record last updated
- June 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AZITHROMYCIN | 200 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 26, 2013: NOC 14941Supplement to an Abbreviated New Drug Submission (SANDS) · Product name change
- April 18, 2006: NOC 7891Supplement to an Abbreviated New Drug Submission (SANDS) · New dosage form
Other DINs named AZITHROMYCIN
- DIN 02330881 · Marketed
- DIN 02442434 · Marketed
- DIN 02545969 · Marketed
- DIN 02274388 · Cancelled Post Market
- DIN 02330911 · Cancelled Post Market
- DIN 02342030 · Cancelled (Unreturned Annual)
- DIN 02342049 · Cancelled (Unreturned Annual)
- DIN 02343347 · Cancelled Pre Market
- DIN 02343355 · Cancelled Pre Market
- DIN 02418363 · Cancelled Pre Market
- DIN 02418371 · Cancelled Pre Market
- DIN 02477629 · Cancelled Pre Market
- DIN 02545977 · Approved